address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,forwardPE,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,marketState,shortName,longName,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketChangePercent,regularMarketPrice,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,corporateActions,regularMarketTime,trailingPegRatio
Mahendra Industrial Estate,"Ground Floor Road No. 29, Plot No. 109-D Sion (East)",Mumbai,400 022,India,91 22 2401 9025,91 22 2407 3462,https://www.aartidrugs.co.in,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.","[{'maxAge': 1, 'name': 'Mr. Prakash Moreshwar Patil', 'age': 77, 'title': 'Chairman, MD, CEO & Head of BR', 'yearBorn': 1947, 'fiscalYear': 2024, 'totalPay': 27848000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Harshit Manila Savla', 'age': 62, 'title': 'Joint MD & Executive Director', 'yearBorn': 1962, 'fiscalYear': 2024, 'totalPay': 25542000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Adhish Prakash Patil', 'age': 41, 'title': 'CFO & COO', 'yearBorn': 1983, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Rushikesh Vivek Deole', 'title': 'Company Secretary & Compliance Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Harit Pragji Shah', 'age': 61, 'title': 'Whole-Time Director', 'yearBorn': 1963, 'fiscalYear': 2024, 'totalPay': 25542000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Uday Moreshwar Patil', 'age': 61, 'title': 'Whole-Time Director', 'yearBorn': 1963, 'fiscalYear': 2024, 'totalPay': 3351000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Rashesh Chandrakant Gogri', 'age': 50, 'title': 'MD & Executive Director', 'yearBorn': 1974, 'fiscalYear': 2024, 'totalPay': 25542000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Dhanaji L. Kakade', 'title': 'Vice President of Technical', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Vishwa Harshit Savla', 'title': 'Managing Director of the Pinnacle Life Science Private Limited', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,2,439.75,442.4,431.0,443.25,439.75,442.4,431.0,443.25,1.0,0.23,1738627200,0.0545,2.33,0.412,24.026716,231689,231689,475343,201975,201975,0.0,0.0,0,0,40218124288,312.0,635.0,1.6848605,420.664,430.6935,1.0,0.0022740194,INR,False,46106365952,15.570672,0.07045,35501281,91270000,0.60609,0.10457,92722800,149.836,2.940882,1743379200,1774915200,1743379200,0.329,1681600000,18.34,4:1,1601424000,1.932,16.062,-0.13715297,0.094471335,1.0,1738627200,EQUITY,440.65,461.0,461.0,461.0,461.0,none,1,226100000,2.475,2870599936,6150700032,0.936,1.599,23870300160,44.917,260.478,0.057740003,0.1268,8449299968,-145446496,2445799936,0.338,0.092,0.35397,0.12026,0.118669994,INR,AARTIDRUGS.NS,en-US,US,Equity,Delayed Quote,True,HIGH,POSTPOST,AARTI DRUGS LTD.,Aarti Drugs Limited,NSI,finmb_9900311,Asia/Kolkata,IST,19800000,in_market,False,0.20466034,440.65,False,False,1063943100000,0.8999939,431.0 - 443.25,NSE,475343,128.65,0.41233972,312.0 - 635.0,-194.35,-0.306063,-13.715297,1746529140,1753354740,1753704000,1746595800,1746595800,True,18.34,23.2,18.993534,19.985992,0.047510583,9.956482,0.023117324,15,15,[],1750413603,
